Yimitasvir
- Generic Name
- Yimitasvir
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
与索磷布韦片联合，用于治疗成人基因1型非肝硬化慢性丙型肝炎（HCV）。
- Associated Conditions
- -
- Associated Therapies
- -
The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects
- First Posted Date
- 2018-03-12
- Last Posted Date
- 2018-03-12
- Lead Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT03462173
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath